Laura Berner
About Laura Berner
Laura Berner Chief Operating Officer
Laura Berner serves as the Chief Operating Officer at her current organization. In this role, she oversees the company's daily operations and implements strategies to improve efficiency and achieve organizational goals. Berner's expertise includes a comprehensive understanding of business development, legal affairs, and corporate governance, shaped by an extensive career in various high-level positions within the biotech and pharmaceutical sectors.
Laura Berner Education
Laura Berner holds a Juris Doctor (JD) from Stanford Law School, where she gained a strong foundation in legal principles and jurisprudence. She also earned a Master of Business Administration (MBA) from the Gies College of Business at the University of Illinois Urbana-Champaign, equipping her with advanced business management skills. Additionally, she obtained a Bachelor of Arts (BA) in biology from Bryn Mawr College, providing her with a scientific background that complements her roles in the biotech field.
Laura Berner Career Background
Laura Berner's career began as a corporate attorney at Ropes & Gray LLP, where she developed her legal expertise. She later worked in the Office of the General Counsel at Harvard University, expanding her experience in legal affairs within the higher education sector. Subsequently, she joined Roche Pharma Partnering as part of the Transactions team, furthering her knowledge in pharmaceutical partnerships and deals.
Laura Berner Previous Leadership Roles
Prior to her current role, Laura Berner served as Vice President and Head of Business Development & Investor Relations at Myovant Sciences. In this capacity, she led efforts to establish strategic partnerships, manage investor relations, and drive business growth. Her leadership and strategic insights contributed significantly to the company's development and investment strategies.
Laura Berner Board Membership
Laura Berner serves as an independent director on the Board of Directors of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT). In this role, she contributes her expertise in corporate governance and strategic planning to support the company's mission and operations. Her involvement with Bolt Biotherapeutics reflects her ongoing commitment to the biotech industry and her ability to provide valuable insights at the board level.